Pharmaceutical compositions and use of extract of juniperus chinensis for inhibiting angiogenesis

A pharmaceutical composition and angiogenesis technology, applied in the direction of drug combination, pharmaceutical formula, cardiovascular system diseases, etc., can solve problems such as bleeding, stroke, cardiovascular disease, affecting wound healing of patients, etc.

Active Publication Date: 2014-06-25
IND TECH RES INST
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, when the angiogenesis is excessively inhibited, it may also cause bleeding, stroke, cardiovas

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical compositions and use of extract of juniperus chinensis for inhibiting angiogenesis
  • Pharmaceutical compositions and use of extract of juniperus chinensis for inhibiting angiogenesis
  • Pharmaceutical compositions and use of extract of juniperus chinensis for inhibiting angiogenesis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0042] The present invention provides a pharmaceutical composition for inhibiting angiogenesis with the extract of Juniperus chinensis as the main active ingredient, which has the effect of inhibiting angiogenesis.

[0043] The above-mentioned pharmaceutical composition for inhibiting angiogenesis of the present invention may include, but not limited to, an effective amount of Juniper extract, wherein the Juniper extract is the active ingredient for inhibiting angiogenesis. In one embodiment, the pharmaceutical composition for inhibiting angiogenesis of the present invention may further include a pharmaceutically acceptable carrier or salt.

[0044] In the present invention, examples of Juniper (Juniperus chinensis) used to extract the Juniper extract may include, but not limited to, Juniperus chinensis var. Shimpaku, Juniperus chinensis L. var. sargentii Henry, Juniperus (original variety) (Juniperus chinensis L.var.chinensis), Qingshui Juniper (Juniperus chinensis L.var.taiw...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract of Juniperus chinensis or an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Description

technical field [0001] The present invention relates to a pharmaceutical composition for inhibiting angiogenesis, and in particular to a pharmaceutical composition for inhibiting angiogenesis with Juniperus chinensis extract as an active ingredient. Background technique [0002] Angiogenesis refers to the process of growing new blood vessels near the original existing blood vessels. Under the normal physiological mechanism, it can transmit the response to the stimulus by promoting angiogenesis. For example, in the process of wound healing or female menstrual cycle, there will be an angiogenesis response that is controllable and lasts for about 1-2 weeks. However, pathological angiogenesis is not controlled by normal physiological mechanisms. The regulation of angiogenesis plays a very important and balanced role in the human body. Under the action of strong angiogenesis, it may cause diabetic retinopathy, rheumatoid arthritis, or accelerate the deterioration and metastasis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/14A61K31/365A61K31/7048A61P35/00A61P27/02A61P9/10A61P9/14
CPCA61K31/7048A61K36/14A61K31/365A61P9/00A61P9/10A61P9/14A61P27/02A61P35/00A61P43/00A61K2300/00
Inventor 潘一红姚心然林美薇吕亦晃吴信颉曾湘文柯景怀王俊中郭宗铿林士弘郑奕正童天送
Owner IND TECH RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap